Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)

1 Jan 2016

Abstract excerpt

followed up for a long term and, at the same time, if the rates of CVD and death are precisely recorded. Although several studies have been published in Korea, it might be difficult to apply the results to actual clinical practice owing to the lack of the abovementioned elements. In addition, it is not possible to quote Western risk evaluation criteria, as the mortality of ischemic heart disease in Korea is among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Diabetes, Cardiovascular Risks, and Lipoproteins
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27275165
DOI: 10.4070/kcj.2016.46.3.275

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)PMID 27275165Read ↗

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Semantic proximity Read ↗

National Lipid Association Annual Summary of Clinical Lipidology 2015.Semantic proximity Read ↗

Awareness, treatment, control, and determinants of dyslipidemia among adults in China: results from the China National Stroke Screening and Prevention Project (CNSSPP)Semantic proximity Read ↗

Trends in Prevalence, Risk-Factors Controls and Medications in ASCVD Among US Adults, 1999-2018Semantic proximity Read ↗

Framingham Risk Score for Cardiovascular Disease: Application to Jordanian Community; A cross sectional studySemantic proximity Read ↗

[Lipoprotein metabolism disorders. II. Epidemiology, classification, and diagnosis].Semantic proximity Read ↗

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Semantic proximity Read ↗

An internist's update on cholesterol management.Semantic proximity Read ↗

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).Semantic proximity Read ↗

Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.Semantic proximity Read ↗

Hyperlipidemia as a risk factor for cardiovascular disease.Semantic proximity Read ↗

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.